| RS2125125105 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS2125125165 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125125269 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS2125125299 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Chuvash polycythemia |
| RS2125125325 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125125896 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125128187 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125128261 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125128271 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, VHL-related disorder |
| RS2125128327 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Von Hippel-Lindau syndrome |
| RS2125128340 |
VHL
|
Health Risk |
Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS2125128363 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS2125130449 |
VHL
|
Health Risk |
Likely pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125130543 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS2125130551 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125130735 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS2125130793 |
VHL
|
Health Risk |
Likely pathogenic |
Von Hippel-Lindau syndrome, Von Hippel-Lindau syndrome |
| RS2125130877 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS2125134167 |
SUMF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2125158367 |
D2HGDH
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS2125159664 |
ITPR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS2125159710 |
ITPR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 15/16, Spinocerebellar ataxia type 15/16 |
| RS2125159718 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS2125165615 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125165857 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125166116 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125166200 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125166454 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125167364 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125167652 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125167896 |
DES
|
Health Risk |
Likely pathogenic |
— |
| RS2125168194 |
DES
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, DES-related disorder |
| RS2125168811 |
DES
|
Health Risk |
Likely pathogenic |
Bradycardia, Progressive familial heart block |
| RS2125168897 |
DES
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Desmin-related myofibrillar myopathy |
| RS2125168913 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2125171543 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2125176154 |
SUMF1
|
Health Risk |
Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS2125177235 |
PPARG
|
Health Risk |
Likely pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS2125187131 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2125187544 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125187619 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125187678 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125187739 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125187905 |
SETD5
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2125193560 |
ITPR1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS2125193661 |
SETD5
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125193922 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2125193925 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 12 |
| RS2125194140 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125194268 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125196920 |
ITPR1
|
Health Risk |
Pathogenic |
— |
| RS2125201760 |
ITPR1
|
Health Risk |
Likely pathogenic |
— |
| RS2125201841 |
ITPR1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 15/16, Spinocerebellar ataxia type 15/16 |
| RS2125208683 |
SATB1
|
Health Risk |
Pathogenic |
Kohlschutter-Tonz syndrome-like, Developmental delay with dysmorphic facies and dental anomalies |
| RS2125212001 |
SETD5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2125212022 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125214086 |
ITPR1
|
Health Risk |
Pathogenic |
— |
| RS2125215016 |
PPARG
|
Health Risk |
Pathogenic |
DIABETES MELLITUS, TYPE II |
| RS2125235547 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2125235756 |
ITPR1
|
Health Risk |
Likely pathogenic |
— |
| RS2125241261 |
ITPR1
|
Health Risk |
Likely pathogenic |
— |
| RS2125252529 |
PPARG
|
Health Risk |
Pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS2125252919 |
IL17RC
|
Health Risk |
Likely pathogenic |
— |
| RS2125253315 |
RPL15
|
Health Risk |
Pathogenic |
— |
| RS2125271279 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125272771 |
ITPR1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS2125273254 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125274409 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2125280717 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2125280753 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125281306 |
SETD5
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Inborn genetic diseases |
| RS2125283014 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS2125283083 |
ITPR1
|
Health Risk |
Pathogenic |
— |
| RS2125283159 |
ITPR1
|
Health Risk |
Likely pathogenic |
— |
| RS2125284331 |
PPARG
|
Health Risk |
Likely pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS2125284643 |
PPARG
|
Health Risk |
Likely pathogenic |
— |
| RS2125285337 |
PPARG
|
Health Risk |
Likely pathogenic |
PPARG-related familial partial lipodystrophy, PPARG-related familial partial lipodystrophy |
| RS2125288295 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2125288672 |
SPEG
|
Health Risk |
Pathogenic |
— |
| RS2125288982 |
SETD5
|
Health Risk |
Pathogenic |
Global developmental delay, Heart |
| RS2125290668 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2125291407 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2125291573 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2125291854 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2125292585 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2125298689 |
PIKFYVE
|
Health Risk |
Likely pathogenic |
Fleck corneal dystrophy, Fleck corneal dystrophy |
| RS2125303600 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2125303667 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2125303672 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2125303994 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2125304158 |
IQSEC1
|
Health Risk |
Likely pathogenic |
— |
| RS2125304648 |
CRB1
|
Health Risk |
Likely pathogenic |
Abnormality of the eye, Retinal dystrophy |
| RS2125304900 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2125314878 |
CYP1B1
|
Health Risk |
Likely pathogenic |
— |
| RS2125314883 |
CYP1B1
|
Health Risk |
Likely pathogenic |
Glaucoma 3A, Glaucoma 3 |
| RS2125316074 |
CYP1B1
|
Health Risk |
Likely pathogenic |
Glaucoma 3A, Primary congenital glaucoma |
| RS2125316235 |
CYP1B1
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 6, Glaucoma 3A |
| RS2125316417 |
CYP1B1
|
Health Risk |
Pathogenic |
Glaucoma, primary open angle |
| RS2125321733 |
NGLY1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital disorder of deglycosylation, Congenital disorder of deglycosylation 1 |
| RS2125322976 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |